EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Engineering magnetotactic bacteria MVs to synergize chemotherapy, ferroptosis and immunotherapy for augmented antitumor therapy

Gexuan Jiang, Zhichu Xiang, Qiaojun Fang

Nanoscale Horizons · 2023

DOI: 10.1039/d3nh00061c ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale Horizons, 2023. Verfasst von Gexuan Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Theoretical and Computational Nanoscience, CAS Key Laboratory of Nanophotonic Materials and Devices, CAS Key Laboratory of Nanophotonic…. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Key Research and Development Program of China, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A magnetotactic bacteria membrane vesicle-based nanovaccine integrating chemotherapy/immunotherapy/ferroptosis-inducing capability in one, may provide an efficacious treatment option for enhancing tumor synergistic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNeoplasmsAnimalsMiceDoxorubicinDrug Delivery SystemsImmunotherapyTumor Microenvironment

Substanzen

Doxorubicin

Autor:innen und Institutionen

  • Laboratory of Theoretical and Computational Nanoscience, CAS Key Laboratory of Nanophotonic Materials and Devices, CAS Key Laboratory of Nanophotonic Materials and Devices, CAS Center for Excellence in Nanoscience, Beij…
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • Sino-Danish Center for Education and Research, Beijing 101408, China.

Förderung

  • National Key Research and Development Program of China
  • Chinese Academy of Sciences

Zitieren

APA

Jiang, G., Xiang, Z., & Fang, Q. (2023). Engineering magnetotactic bacteria MVs to synergize chemotherapy, ferroptosis and immunotherapy for augmented antitumor therapy. Nanoscale Horizons. https://doi.org/10.1039/d3nh00061c

Vancouver

Jiang G, Xiang Z, Fang Q. Engineering magnetotactic bacteria MVs to synergize chemotherapy, ferroptosis and immunotherapy for augmented antitumor therapy. Nanoscale Horizons. 2023. doi:10.1039/d3nh00061c

BibTeX
@article{Jiang2023,
  author = {Jiang, Gexuan and Xiang, Zhichu and Fang, Qiaojun},
  title = {Engineering magnetotactic bacteria MVs to synergize chemotherapy, ferroptosis and immunotherapy for augmented antitumor therapy},
  journal = {Nanoscale Horizons},
  year = {2023},
  doi = {10.1039/d3nh00061c}
}
Kostenlos starten →